Staley Capital Advisers Inc. Sells 200,000 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Staley Capital Advisers Inc. reduced its stake in Option Care Health by 40%, selling 200,000 shares and now holding 300,000 shares valued at approximately $10.5 million.
• Several institutional investors, including Compass Wealth Management and Bessemer Group, have increased their stakes in Option Care Health, indicating robust interest in the company.
• Option Care Health reported Q2 earnings that beat expectations, with an EPS of $0.41 and revenue of $1.42 billion, marking a 15.4% year-over-year increase.

Staley Capital Advisers Inc. lowered its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 40.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 300,000 shares of the company's stock after selling 200,000 shares during the period. Staley Capital Advisers Inc. owned approximately 0.18% of Option Care Health worth $10,485,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of OPCH. Wells Fargo & Company MN increased its position in Option Care Health by 9.5% during the fourth quarter. Wells Fargo & Company MN now owns 180,391 shares of the company's stock worth $4,185,000 after buying an additional 15,609 shares during the last quarter. Bank of Nova Scotia acquired a new position in Option Care Health during the fourth quarter worth $228,000. Renaissance Technologies LLC increased its position in Option Care Health by 2,032.6% during the fourth quarter. Renaissance Technologies LLC now owns 330,546 shares of the company's stock worth $7,669,000 after buying an additional 315,046 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Option Care Health during the fourth quarter worth $2,027,000. Finally, Sterling Capital Management LLC increased its position in Option Care Health by 638.5% during the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock worth $69,000 after buying an additional 2,554 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on OPCH shares. Barrington Research reissued an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, JMP Securities raised their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded up $0.12 during trading on Friday, reaching $28.53. The stock had a trading volume of 403,864 shares, compared to its average volume of 1,829,590. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The stock has a market capitalization of $4.63 billion, a PE ratio of 22.84, a P/E/G ratio of 1.80 and a beta of 0.79. The business's 50-day moving average price is $30.36 and its 200 day moving average price is $31.87. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. Option Care Health's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.30 earnings per share. As a group, equities analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.